Clinical trial
HD11 for Intermediate Stages
NCT00264953 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00264953 |
|---|---|
| Title | HD11 for Intermediate Stages |
| Lead sponsor | University of Cologne, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hodgkin´s Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | Adriamycin, Bleomycin, Vinblastine, DTIC, Etoposide, Procarbazine, Prednisone, Vincristine, radiation therapy |
| Enrollment | 1,395 |
| Start date | May 1, 1998 |
| Primary completion | Jan 1, 2003 |
| First posted | Dec 13, 2005 |
| Last update posted | Aug 4, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: